Henry Schein Orthodontics Launches Carriere® Motion Pro™ Bite Corrector
Henry Schein Orthodontics (HSO), the orthodontics business of Henry Schein, Inc. (Nasdaq: HSIC), expanded its product portfolio with the launch of the Carriere® Motion Pro™ bite corrector1. The newest addition to the Motion portfolio is fitted to teeth to treat…
Universal Health Services Announces Patriot Support Programs’ New Advisory Board
New members bring significant military expertise to guide our Commitment to our Armed Forces Universal Health Services (NYSE: UHS) is pleased to announce a new Advisory Board for its Patriot Support Programs initiative. At subsidiary behavioral health facilities across the…
MWI Animal Health and Hound Announce Strategic Partnership
New partnership expands access among MWI Animal Health’s veterinary practice customers to Hound’s talent management technology a leading provider of state-of-the-art technology solutions and services for veterinary practices, and part of Cencora (formerly AmerisourceBergen), today announced a strategic partnership with Hound, a leading…
Cardinal Health Announces Progress on Business and Portfolio Review and Fiscal 2024 Outlook Update
Cardinal Health (NYSE:CAH) today announced progress on the company’s ongoing business and portfolio review, including an updated enterprise operating and segment reporting structure, and an update to its fiscal year 2024 non-GAAP diluted earnings per share (EPS) outlook. These updates…
Elevance Health Addresses Healthcare’s Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services
Elevance Health gives eligible consumers no-cost access to customized suite of digital and virtual health tools through funding from the Affordable Connectivity Program Elevance Health announced at the Consumer Electronics Show 2024 that it will launch a first-of-its-kind program that…
UnitedHealth Group Reports 2023 Results
UnitedHealth Group (NYSE: UNH) reported full year and fourth quarter 2023results reflecting broad-based growth at Optum and UnitedHealthcare.“UnitedHealth Group enters 2024 well prepared to build on our efforts to improve patient care andconsumer experiences broadly, and to continue delivering strong…
Premier Comments on CY 2025 MA and Medicare Part D Proposed Rule
Premier submitted comments to CMS in response to the proposed rule for the MA and Medicare Prescription Drug Benefit (Part D) Programs for Contract Year 2025. The proposed rule seeks public comment on CMS’ proposals to ensure timely access to care, protect beneficiaries from…
Henry Schein Medical Introduces the Henry Schein ‘RISE’ Platform for Ambulatory Surgery Centers
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), today announced the launch of Henry Schein RISE (Resources, Infection Prevention, Solutions & Support, Education) – a platform designed to provide ambulatory surgery centers (ASCs) with infection prevention resources including access to third-party…
OSI Systems Receives $5 Million Award for Patient Monitoring Solutions
-OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare®, has received an order valued at approximately $5 million to provide patient monitoring solutions and related supplies and accessories to a U.S.…
Thermo Fisher Scientific Launches PangenomiX Array to Support Population-Scale Disease Studies and Pharmacogenomics Research
Most comprehensive and ethnically diverse genomic coverage on a high throughput microarray delivers multi-disease and pharmacogenomic research analysis across global populations -Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people…
The world’s first patients were treated with the new Edison® histotripsy system
Leading US Institutions Launch Innovative Histotripsy Liver Treatment Programs the manufacturer of the non-invasive Edison® histotripsy system, today announced that a patient at the University of Rochester Medical Center had was the first in the world to receive targeted treatment…
Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance
a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for the fourth quarter and full year ended December 31, 2023. Preliminary Fourth Quarter Revenue and Cash Balance Preliminary Full Year 2023 Revenue and Cash Usage “Our…